OCT Clinical Unveils OCT Oncology™ Solution Package
New solution will address needs in oncology clinical research, with a special focus on emerging biotechs.
OCT Clinical has announced the extension of its services via its OCT Oncology™ solution, to address needs in oncology clinical research, with a special focus on emerging biotechs.
To accomodate the specialized attention emerging oncology therapies often require, OCT Clinical focuses on accelerated access, speedy enrollment, and ultimately cost efficiency.
This is achievied with the help of digital solutions that emerging companies can benefit from:
- CTMS with real-time data access and data hub for risk management
- EDC roll-out tailored to early phase oncology (error-checking during data entry at sites allows for early detection and correction of errors to avoid additional costs associated with the double entry of data from paper-based forms)
- eCRF templates that also help to save time and resources
Read more about the new solution package
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025